Pharmaceutical Grade Lithium Carbonate Market : Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

and India Pharmaceutical Grade Lithium Carbonate Market Size
The global Pharmaceutical Grade Lithium Carbonate revenue was US$ 97 million in 2022 and is forecast to a readjusted size of US$ 144.6 million by 2029 with a CAGR of 5.8% during the forecast period (2023-2029).

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-12G16274/Global_and_India_Pharmaceutical_Grade_Lithium_Carbonate_Market_Report_Forecast_2023_2029

and India Pharmaceutical Grade Lithium Carbonate Market
Lithium carbonate, also known as lithium salt, is the most widely used mood stabilizer in psychiatry. In contrast to tricyclic anti-depressants, lithium can significantly inhibit the release of norepinephrine and dopamine in the central nervous system and increase the re-uptake of neurons to exert an anti-manic effect. In the psychiatric department, lithium carbonate is used as a mood stabilizer for the treatment of mania and is regarded as a specific drug for bipolar disorder, as well as for the prevention of mania and depression. In addition, lithium carbonate is also used in the treatment of schizoaffective psychosis, schizophrenia, epilepsy caused by mental disorders, and used to control the excitement of the patient's impulsive aggressive behaviour.
In India, the Pharmaceutical Grade Lithium Carbonate revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The major players in global Pharmaceutical Grade Lithium Carbonate market include Albemarle, Essential Pharma, Livent, etc. The top 3 players occupy about 45% shares of the global market. Americas and Europe are main markets, they occupy about 80% of the global market. 0.985-0.99 is the main type, with a share over 70%. Lithium Carbonate Sustained-release Tablets is the main application, which holds a share about 95%.
This report focuses on global and India Pharmaceutical Grade Lithium Carbonate market, also covers the segmentation data of other regions in regional level and county level.
India is now the world's most populous country. According to IMF (its July update to its World Economic Outlook), India's GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Pharmaceutical Grade Lithium Carbonate will continue to grow rapidly in the future.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-12G16274/Global_and_India_Pharmaceutical_Grade_Lithium_Carbonate_Market_Report_Forecast_2023_2029

Segment by Type
• 0.98-0.985
• 0.985-0.99
• Above 0.99

Segment by Application
• Lithium Carbonate Sustained-release Tablets
• Lithium Carbonate Ordinary Tablets

By Company
Livent, Albemarle, Globe Quimica, ANI Pharmaceuticals, Essential Pharma, Taj Pharma, Axiom Lithium, Jiangsu Nhwa Pharmaceutical, Qianjin Group, Jiangsu Lianhuan Pharmaceutical

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-12G16274/global-and-india-pharmaceutical-grade-lithium-carbonate

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.